Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 3/20 | 0.48 |
| ▸ | FNTB | P49356 | 3/20 | 0.48 |
| ▸ | RRM1 | P23921 | 1/20 | 0.47 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.47 |
| ▸ | PGGT1B | P53609 | 2/20 | 0.46 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.45 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.45 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.45 |
| ▸ | ALDH1A2 | O94788 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.44 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.44 |
| ▸ | S1PR2 | O95136 | 2/20 | 0.42 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.42 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.42 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.39 |
| ▸ | TLR2 | O60603 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2452784 | 0.85 | GNAI3 (0.61) | FNTAFNTBRRM1DPP7PGGT1B | |
| SCHEMBL18807791 | 0.85 | FNTA (0.48) | FNTAFNTBRRM1DPP7PGGT1B | |
| SCHEMBL930389 | 0.85 | DPP7 (0.50) | FNTAFNTBRRM1DPP7PGGT1B | |
| SCHEMBL19385712 | 0.84 | MMP2 (0.47) | FNTAFNTBRRM1DPP7PGGT1B | |
| SCHEMBL5654571 | 0.84 | DPP7 (0.69) | FNTAFNTBRRM1DPP7PGGT1B | |
| SCHEMBL9491467 | 0.84 | DPP7 (0.69) | FNTAFNTBRRM1DPP7PGGT1B | |
| SCHEMBL9491462 | 0.84 | DPP7 (0.69) | FNTAFNTBRRM1DPP7PGGT1B | |
| SCHEMBL930618 | 0.82 | DPP7 (0.47) | FNTAFNTBRRM1DPP7PGGT1B | |
| SCHEMBL14854295 | 0.82 | FNTA (0.55) | FNTAFNTBRRM1DPP7PGGT1B | |
| SCHEMBL14854237 | 0.82 | FNTA (0.55) | FNTAFNTBRRM1DPP7PGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1578962-A4 | CARRIER-LIGAND FUSIONS AND USES THEREOF | NEW ENGLAND BIOLABS INC (US) | 2007-03-14 | — | — | EP | disclosed |
| EP-1578962-A2 | CARRIER-LIGAND FUSIONS AND USES THEREOF | NEW ENGLAND BIOLABS, INC. (US) | 2005-09-28 | — | — | EP | disclosed |
| US-20040198958-A1 | Carrier-ligand fusions and uses thereof | NEW ENGLAND BIOLABS, INC. | 2004-10-07 | — | — | US | disclosed |
| WO-2004053460-A2 | CARRIER-LIGAND FUSIONS AND USES THEREOF | NEW ENGLAND BIOLABS, INC. (US) | 2004-06-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040198958-A1 | Carrier-ligand fusions and uses thereof | SCLY, LANCL1, SELENOI | FNTA 110/4885FNTB 41/4885RRM1 2703/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.